Cardinal Health's Outcomes Business Merges With Transaction Data Systems, Marking New Chapter

Cardinal Health, Inc. CAH has inked a pact to contribute its Outcomes business to Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity.
As a part of the agreement, Cardinal Health's pharmaceutical segment CEO, Debbie Weitzman, will be appointed to the TDS board of directors after the deal.
The transaction will close in the third calendar quarter of 2023.
Together, TDS and Outcomes will create "additional opportunities" for pharmacists to participate in sponsored clinical interventions and provide better access for payors and pharmaceutical companies to drive better patient care and outcomes.
The transaction will create a broad, integrated offering of pharmacy workflow software with patient engagement and clinical solutions to serve the patient, pharmacy, payer, and pharmaceutical company ecosystem, including one of the nation's largest networks of 40,000 retail, chain and grocery pharmacies.
"Bringing together the powerful connections and unified platform of Outcomes with TDS's best-in-class pharmacy management solutions will enable pharmacies to offer an elevated level of personal care for their patients..," said Debbie Weitzman, CEO of Cardinal Health's pharmaceutical segment.
Price Action: CAH shares are trading higher by 0.06% to $84.64 on the last check Monday.